Lung Therapeutics, Inc.

Pharmaceutical company · Austin, Texas, United States

Lung Therapeutics, Inc. is a pharmaceutical company headquartered in Austin, Texas, United States. Its earliest recorded incorporation is in 2012. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Lung Therapeutics at a glance

Typepharmaceutical company
HeadquartersAustin, Texas, United States
Earliest incorporation on record2012
SEC industryPharmaceutical Preparations
Employees (per SBIR records)23
SEC CIK1611241

What does Lung Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $1 million in total (2018 to 2023). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

10 Form D notices; the most recent reported $10.1 million sold (2022).

Frequently asked questions about Lung Therapeutics

Where is Lung Therapeutics headquartered?

Lung Therapeutics, Inc. is headquartered in Austin, Texas, United States.

What does Lung Therapeutics do?

Lung Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was Lung Therapeutics founded?

The earliest incorporation on record for Lung Therapeutics, Inc. is in 2012, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

Lung Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX